Our privacy policy describes how Fidessa uses cookies on our website. If you continue using our website, you are consenting to our use of cookies. OK

Now with added derivatives

Spent an interesting week in Boca Raton at the FIA’s annual conference which brings together the top executives from the global futures industry to debate what lies ahead. The event had extra spice this year as the recent wave of merger mania in the exchange space has placed a high premium on those venues that have – or that can create – a derivatives capability. Because derivatives exchanges own the products being traded, rather than simply providing a marketplace, derivatives venues are better able to protect margins and fight off competitors than their equities-only counterparts. Just look at the success of CBOE’s VIX contract which is now widely regarded as a universal (and tradable) fear gauge of overall financial market sentiment.

This fact helps explain why derivatives are becoming such an important part of the changing exchange landscape. And of course they are attracting their own share of regulatory attention with plans afoot to move the OTC market onto exchange and increase its overall regulatory transparency. In Europe especially, the potential merger between Deutsche Börse and NYSE Euronext would combine both the Liffe and Eurex markets into a potent force. Maybe the price for allowing the merger to go ahead will be that some sort of fungibility (or other clearing compatibility) is mandated by Brussels. If that were to happen then expect every venue to launch its own variant of the major derivatives contracts.

Leave a comment

Copyright © 2017 Fidessa group plc. All rights reserved.

The information contained within this website is provided for informational purposes only. Fidessa will use reasonable care to ensure that information is accurate at the time it is made available, and for the duration that it remains on the site. The information may be changed by Fidessa at any time without notice. We also reserve the right to close the website at any time. No representation or warranty, expressed or implied, is given on behalf of Fidessa or any of its respective directors, employees, agents, or advisers as to the accuracy or completeness of the information or opinions contained herein or its suitability for any purpose and, save in the case of fraud, all liability for direct, indirect, special, consequential or other loss or damages of whatever kind that may arise from use of the website is hereby excluded to the fullest extent permitted by law. Any decisions you make based on the information in this website are your sole responsibility and information on the website should not be relied upon in connection with any investment decision.

The copyright of this website belongs to Fidessa. All other intellectual property rights are reserved.

Fragulator® is a registered trademark of Fidessa group plc.

Reproduction or redistribution of this information is prohibited except with written permission from Fidessa.